Literature DB >> 7426142

Treatment of acute myocardial infarction with propranolol. Further studies on enzyme appearance and subsequent left ventricular function in treated and control patients with developing infarcts.

R M Norris, N L Sammel, E D Clarke, P W Brandt.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7426142      PMCID： PMC482762          DOI： 10.1136/hrt.43.6.617

Source DB:  PubMed          Journal:  Br Heart J        ISSN： 0007-0769


× No keyword cloud information.
  15 in total

1.  Distribution of coronary collateral flow in acute myocardial ischaemic injury: effect of propranolol.

Authors:  R A Kloner; K A Reimer; R B Jennings
Journal:  Cardiovasc Res       Date:  1976-01       Impact factor: 10.787

2.  The effect of propranolol on canine myocardial CPK distribution space and rate of disappearance.

Authors:  J A Cairns; G A Klassen
Journal:  Circulation       Date:  1977-08       Impact factor: 29.690

3.  Effects of propranolol on regional myocardial function, electrograms, and blood flow in conscious dogs with myocardial ischemia.

Authors:  S F Vatner; H Baig; W T Manders; H Ochs; M Pagani
Journal:  J Clin Invest       Date:  1977-08       Impact factor: 14.808

4.  Propranolol in the treatment of acute myocardial infarction. Effect on myocardial oxygenation and hemodynamics.

Authors:  H S Mueller; S M Ayres; A Religa; R G Evans
Journal:  Circulation       Date:  1974-06       Impact factor: 29.690

5.  A simple and rapid fluorometric method for the estimation of 1-(2-hydroxy-3-isopropylamino-propoxy)-naphthalene hydrochloride, propranolol, in blood.

Authors:  P K Ambler; B N Singh; M Lever
Journal:  Clin Chim Acta       Date:  1974-08-20       Impact factor: 3.786

6.  An improved procedure for serum creatine phosphokinase determination.

Authors:  S B Rosalki
Journal:  J Lab Clin Med       Date:  1967-04

7.  Estimation of infarct size in man and its relation to prognosis.

Authors:  B E Sobel; G F Bresnahan; W E Shell; R D Yoder
Journal:  Circulation       Date:  1972-10       Impact factor: 29.690

8.  Factors influencing infarct size following experimental coronary artery occlusions.

Authors:  P R Maroko; J K Kjekshus; B E Sobel; T Watanabe; J W Covell; J Ross; E Braunwald
Journal:  Circulation       Date:  1971-01       Impact factor: 29.690

9.  Correlation of coronary arteriograms and left ventriculograms with postmortem studies.

Authors:  G M Hutchins; B H Bulkley; R L Ridolfi; L S Griffith; F T Lohr; M A Piasio
Journal:  Circulation       Date:  1977-07       Impact factor: 29.690

10.  Clinical measurement of myocardial infarct size. Modification of a method for the estimation of total creatine phosphokinase release after myocardial infarction.

Authors:  R M Norris; R M Whitlock; C Barratt-Boyes; C W Small
Journal:  Circulation       Date:  1975-04       Impact factor: 29.690
View more
  10 in total

Review 1.  According to MIAMI and ISIS-I trials, can a general recommendation be given for beta blockers in acute myocardial infarction?

Authors:  J K Kjekshus
Journal:  Cardiovasc Drugs Ther       Date:  1988-05       Impact factor: 3.727

2.  Early intravenous beta-blockers in patients with acute coronary syndrome--a meta-analysis of randomized trials.

Authors:  Saurav Chatterjee; Debanik Chaudhuri; Rajesh Vedanthan; Valentin Fuster; Borja Ibanez; Sripal Bangalore; Debabrata Mukherjee
Journal:  Int J Cardiol       Date:  2012-11-17       Impact factor: 4.164

3.  Limitation of myocardial infarct size. Present status.

Authors:  S Yusuf; P Sleight
Journal:  Drugs       Date:  1983-05       Impact factor: 9.546

4.  Intravenous beta-blockers during unstable angina and threatened infarction.

Authors:  R M Norris; P F Barnaby; G G Geary
Journal:  Br J Clin Pharmacol       Date:  1982       Impact factor: 4.335

Review 5.  Beta-adrenoceptor blockers. An update on their role in acute myocardial infarction.

Authors:  R M Norris
Journal:  Drugs       Date:  1985-02       Impact factor: 9.546

6.  Effect of early treatment with propranolol on left ventricular function four weeks after myocardial infarction.

Authors:  M A Brown; R M Norris; P F Barnaby; G G Geary; P W Brandt
Journal:  Br Heart J       Date:  1985-10

Review 7.  Combined receptor intervention and myocardial infarction.

Authors:  D A Chamberlain; R Vincent
Journal:  Drugs       Date:  1984       Impact factor: 9.546

8.  Reduced risk of death at 28 days in patients taking a beta blocker before admission to hospital with myocardial infarction.

Authors:  S M Nidorf; R W Parsons; P L Thompson; K D Jamrozik; M S Hobbs
Journal:  BMJ       Date:  1990-01-13

Review 9.  Metoprolol. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in hypertension, ischaemic heart disease and related cardiovascular disorders.

Authors:  P Benfield; S P Clissold; R N Brogden
Journal:  Drugs       Date:  1986-05       Impact factor: 9.546

10.  Beta-blockers for suspected or diagnosed acute myocardial infarction.

Authors:  Sanam Safi; Naqash J Sethi; Emil Eik Nielsen; Joshua Feinberg; Janus C Jakobsen; Christian Gluud
Journal:  Cochrane Database Syst Rev       Date:  2019-12-17
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.